# Safety, Tolerability and Pharmacokinetics of SP-8203

> **NCT01757795** · PHASE1 · COMPLETED · sponsor: **Shin Poong Pharmaceutical Co. Ltd.** · enrollment: 72 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** SP-8203
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01757795
- **Lead sponsor:** Shin Poong Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-23
- **Primary completion:** 2015-03-11
- **Final completion:** 2015-03-11
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757795, "Safety, Tolerability and Pharmacokinetics of SP-8203". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01757795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*